Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2020-11-25
2021-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measures of Motor Impairment in Early Parkinson's Disease
NCT00291265
Automated Telehealth Diagnostics for Remote Parkinson Monitoring
NCT02152319
Prospective Memory Training in Parkinson Disease
NCT03582670
Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
NCT01648803
Remote Monitoring in Parkinson's Disease
NCT05780866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with PD
No interventions assigned to this group
Care Partners of PD participants
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 30 years of age
* Clinical diagnosis of PD by a neurologist or other movement disorder specialist as reported by the participant, with current motor symptoms
* Able to ambulate independently (assistance of minor walking aids such as a cane is permitted, but depending on a walker for ambulation is not)
* Have a BMI of 33 or below calculated by participant reported height and weight at the time of screening
* Able to read, understand, and provide written informed consent in English
* Able, either alone or with a care partner, to operate digital devices
* Have reliable wifi in their home and the ability to connect new devices to their home wifi
Care partners
* At least 18 years of age
* Able to read, understand, and provide written informed consent in English
* Able to operate digital devices
* Care partner for the participant with PD enrolled in the study
* Lives with the participant with PD enrolled in the study
* Able to ambulate independently (assistance of minor walking aids such as a cane is permitted, but depending on a walker for ambulation is not)
* Willing to exclude pet from the participant's bedroom at night for the duration of the study
Exclusion Criteria
* Any non-PD forms of Parkinsonism
* Active psychiatric disorders that affect the ability to complete study tasks
* Any other medical condition that is the primary cause of the present movement disorder
* Cognitive dysfunction (score \> 7 on the Six-Item Cognitive Impairment Test)
* Considered by the investigator to be an unsuitable participant
* Live in a household with more than three people
* Unwilling to exclude pet from their bedroom at night for the duration of the study
Care partners
* Cognitive dysfunction (score \> 7 on the Six-Item Cognitive Impairment Test)
* Considered by the investigator to be an unsuitable participant
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HealthMode Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mobile Clinical Research Site
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM041001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.